These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 25043538)

  • 1. [Introduction. Justification].
    Núñez-Cortés JM
    Clin Investig Arterioscler; 2014 Jul; 26 Suppl 1():1-2. PubMed ID: 25043538
    [No Abstract]   [Full Text] [Related]  

  • 2. [Determining cardiovascular risk in patients with rheumatoid arthritis: prove the efficacy of interventions first].
    Thomas S
    Ned Tijdschr Geneeskd; 2011; 155(29):A3563. PubMed ID: 21791140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lack of sleep could have health consequences for heart.
    Mayo Clin Womens Healthsource; 2009 Jun; 13(6):3. PubMed ID: 19415044
    [No Abstract]   [Full Text] [Related]  

  • 4. New concept in the pathogenesis of cardiovascular disease.
    Albu JB; Rozanski A; Epstein SE
    AIDS Read; 2003 Apr; 13(4 Suppl):S20-4. PubMed ID: 12762290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiovascular disease and hormone replacement therapy in post-menopausal women.
    Rapeport N
    Cardiovasc J S Afr; 2005; 16(2):76-80. PubMed ID: 15915271
    [No Abstract]   [Full Text] [Related]  

  • 6. Focus on: physical exercise in hemodialysis patients.
    Tentori F
    J Nephrol; 2008; 21(6):808-12. PubMed ID: 19034864
    [No Abstract]   [Full Text] [Related]  

  • 7. [Cardiovascular diseases, cognitive abilities and quality of life in old age].
    Stähelin HB; Ermini-Fünfschilling D; Meier D
    Praxis (Bern 1994); 1995 Oct; 84(44):1256-8. PubMed ID: 7491448
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention of cardiovascular risk and arterial hypertension. Introduction.
    Safar ME
    J Cardiovasc Pharmacol; 1990; 16 Suppl 1():v-vi. PubMed ID: 1706006
    [No Abstract]   [Full Text] [Related]  

  • 9. A new dawn in cardiovascular protection: total cardiovascular risk: rigorous treatment of risk factors. Introduction.
    Ritz E; Dahlöf B
    Nat Clin Pract Cardiovasc Med; 2008 Jul; 5 Suppl 1():S1-2. PubMed ID: 18580859
    [No Abstract]   [Full Text] [Related]  

  • 10. [Life style and cardiovascular risk factors].
    Barriales Alvarez V; Rodríguez Blanco VM
    Med Clin (Barc); 1995 Sep; 105(9):338-40. PubMed ID: 7500687
    [No Abstract]   [Full Text] [Related]  

  • 11. [Sports and prevention of cardiovascular diseases].
    Heitkamp HC; Röcker K; Horstmann T; Dickhuth HH
    Internist (Berl); 1992 Mar; 33(3):130-5. PubMed ID: 1582775
    [No Abstract]   [Full Text] [Related]  

  • 12. [The basic antihypertensive drugs for the long-term secondary prevention of cardiovascular diseases (the working group of the multicenter study Captopril and the Quality of Life)].
    Metelitsa VI; Ostrovskaia TP; Duda SG; Filatova NP; Vygodin VA; Mukhamedzhanova GF
    Ter Arkh; 1994; 66(9):78-82. PubMed ID: 7992223
    [No Abstract]   [Full Text] [Related]  

  • 13. [Prevention of cardiovascular diseases].
    Fazio S
    Prof Inferm; 1988; 41(1):3-14. PubMed ID: 3130632
    [No Abstract]   [Full Text] [Related]  

  • 14. A long-term pulmonary rehabilitation program progressively improves exercise tolerance, quality of life and cardiovascular risk factors in patients with COPD.
    Reis LF; Guimarães FS; Fernandes SJ; Cantanhede LA; Dias CM; Lopes AJ; De Menezes SL
    Eur J Phys Rehabil Med; 2013 Aug; 49(4):491-7. PubMed ID: 23480981
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New directions in the management of hypertension and the cardiovascular risk. Introduction.
    Messerli FH
    Am J Hypertens; 1999 Aug; 12(8 Pt 2):63S-64S. PubMed ID: 10478698
    [No Abstract]   [Full Text] [Related]  

  • 16. [Cardiovascular risk factors and prevention].
    Bongard V; Ferrières J
    Rev Prat; 2006 Jan; 56(1):79-87, 94. PubMed ID: 16548253
    [No Abstract]   [Full Text] [Related]  

  • 17. The cost effectiveness of preventing cardiovascular diseases.
    Grover SA
    Can J Cardiol; 1999 Dec; 15 Suppl G():114G-6G. PubMed ID: 10692671
    [No Abstract]   [Full Text] [Related]  

  • 18. Health-related quality of life and risk factor control: the importance of educational level in prevention of cardiovascular diseases.
    Ose D; Rochon J; Campbell SM; Wensing M; Freund T; van Lieshout J; Längst G; Szecsenyi J; Ludt S
    Eur J Public Health; 2014 Aug; 24(4):679-84. PubMed ID: 24068548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Three-year cardiovascular events and disease progress in patients with peripheral arterial disease: results from the Japan Medication Therapy for Peripheral Arterial Disease (J-METHOD).
    Shigematsu H; Nishibe T; Obitsu Y; Matsuzaki K; Ishida A; Miyata T; Shindo S; Hida K; Ohta T; Ando M; Kawasaki T; Yasugi T; Matsumoto T
    Int Angiol; 2010 Apr; 29(2 Suppl):2-13. PubMed ID: 20357743
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pay attention to global cardiovascular diseases risk of hypertension patients].
    Wu ZS
    Zhonghua Xin Xue Guan Bing Za Zhi; 2007 Oct; 35(10):883-4. PubMed ID: 18206030
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.